Glucagon-like peptide-1 drugs appear to slow the speed at which alcohol enters the bloodstream, which diminishes its effects ...

The GLP-1 food market is booming, with global value hitting $53bn and major brands like Nestlé and General Mills launching ...

Across the US, roughly 1 in 10 adults struggle with alcohol use disorder — a medical condition that makes quitting feel ...

For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says.

People with excess body fat who also had stronger handgrip strength were less likely to develop obesity-related heart, liver ...

Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know. The secondary endpoints included weight loss, and, here again, orforglipron demonstrated ...

Discover how FTIR spectroscopy enhances quality control in GLP-1 weight loss drug production by ensuring molecular ...

Eli Lilly and Company's strong Phase 3 diabetes drug results boost its GLP-1 franchise. Click for my updated look at LLY ...

A raft of favorable Supreme Court emergency decisions this year — stripping protections for hundreds of thousands of immigrants with temporary protections, among them — has given Trump space to ...

The multinational food and beverage brand’s chief marketer for North America talks with The Drum at Groceryshop on using AI, ...

Scientists discovered that Gila monster venom contains a compound that slows digestion. It led to one of the biggest medical ...

Stories like Mendosa’s have become commonplace in the age of Ozempic. According to a 2024 Kaiser Family Foundation survey, ...